{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:17Z","timestamp":1740144197364,"version":"3.37.3"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.81674029"],"award-info":[{"award-number":["No.81674029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Foundation of Heilongjiang University of Chinese Medicine","award":["No.2019MS10"],"award-info":[{"award-number":["No.2019MS10"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Glaucoma is a common ophthalmic neurodegenerative disease and the main cause of blindness, which seriously affects the life and work of patients, without more effective treatment for optic nerve damage. Bushen Huoxue (BSHX) method is a traditional Chinese medicine (TCM) therapy that has been widely used as an alternative therapy to treat optic nerve damage in glaucoma patients with growing beneficial effect evidence, however, there is no current systematic review has addressed its effect for glaucoma. This study will conduct a systematic review and meta-analysis of the currently published randomized controlled trials (RCTs) of BSHX method for the treatment of glaucoma, aim to assess the efficacy and safety of BSHX method for patients with glaucoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will thoroughly search literatures of RCTs related to BSHX method for glaucoma in PubMed, Medline, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP and Wanfang database and other databases from the establishment of the database to November 2019, with no language restriction. After reviewing the title, abstract and full text, 2 reviewers will independently select the study, extract the data, after assess the risk of bias, we will conduct a meta-analysis of the data extracted from the included RCTs, including total effective rate, intraocular pressure (IOP), visual acuity, visual field, TCM syndrome score, and adverse events. The meta-analysis will be performed using Review Manager 5.3 software and the results will be based on either random effects or fixed effects models, depending on the heterogeneity. Trial sequential analysis (TSA) and Grading of Recommendations, Development and Evaluate system (GRADE) will be conduct to evaluate the reliability and quality of evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The results of the study will be published in a peer-reviewed journal, and provide a reasonable and high-quality evidence for the efficacy and safety of BSHX method for glaucoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study will be the first meta-analysis to evaluate the efficacy of BSHX method in the treatment of glaucoma comprehensively, and will to provide helpful evidence for the clinical treatment of this disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration:<\/jats:title>\n            <jats:p>PROSPERO CRD42020159897<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021156","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T16:40:14Z","timestamp":1593448814000},"page":"e21156","source":"Crossref","is-referenced-by-count":1,"title":["The effect of Bushen Huoxue method in treating glaucoma"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7541-8802","authenticated-orcid":false,"given":"Liyuan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyang","family":"Yu","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoxi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"R1-20240214","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open-angle glaucoma","volume":"360","author":"Kwon","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20240214","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"R3-20240214","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaophthalmol.2015.1110","article-title":"The prevalence and types of glaucoma in an Urban Chinese population: The Singapore Chinese eye study","volume":"133","author":"Baskaran","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R4-20240214","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bjophthalmol-2014-306102","article-title":"Glaucoma in Asia: regional prevalence variations and future projections","volume":"100","author":"Chan","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R5-20240214","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R6-20240214","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"R7-20240214","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2147\/DDDT.S80594","article-title":"Neuroprotective therapies for glaucoma","volume":"9","author":"Song","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"R8-20240214","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.neuro.051508.135728","article-title":"Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy","volume":"35","author":"Nickells","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"R9-20240214","doi-asserted-by":"crossref","first-page":"1000.e7","DOI":"10.1016\/j.amjmed.2016.03.038","article-title":"Emerging concepts in glaucoma and review of the literature","volume":"129","author":"Greco","year":"2016","journal-title":"Am J Med"},{"key":"R10-20240214","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00055735-200204000-00002","article-title":"Current understanding of neuroprotection in glaucoma","volume":"13","author":"Wein","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"R11-20240214","first-page":"668","article-title":"Glaucoma","volume":"93","author":"Gupta","year":"2016","journal-title":"Am Fam Physician"},{"key":"R12-20240214","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/med-2016-0006","article-title":"A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma","volume":"11","author":"Chao","year":"2016","journal-title":"Open Med (Wars)"},{"key":"R13-20240214","doi-asserted-by":"crossref","first-page":"e0126","DOI":"10.1097\/MD.0000000000010126","article-title":"Evidence-based practice guideline of Chinese herbal medicine for primary open-angle glaucoma (Qingfeng -Neizhang)","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R14-20240214","first-page":"155","article-title":"Clinical study on treating primary angle-closure glaucoma with tonifying kidney and activating blood circulation (Chinese)","volume":"22","author":"Song","year":"2016","journal-title":"Contemp Med"},{"key":"R15-20240214","first-page":"10","article-title":"Clinical observation of primary angle-closure glaucoma treated with tonifying kidney and activating blood (Chinese)","volume":"36","author":"Zhang","year":"2014","journal-title":"Hubei J Traditional Chin Med"},{"key":"R16-20240214","first-page":"132","article-title":"Neuroprotective effects of kidney-tonifying and blood-activating medicinal on optical nerve in glaucomatous eyes after filtering surgery (Chinese)","volume":"39","author":"Wang","year":"2016","journal-title":"J Beijing Univ Traditional Chin Med"},{"key":"R17-20240214","first-page":"4788","article-title":"Effects of traditional Chinese medicine of tonifying kidney and activating blood on PI3K\/Akt apoptosis-related factors Caspase-9 and NF-(B in chronic ocular hypertension model (Chinese)","volume":"34","author":"Liu","year":"2019","journal-title":"Chinese J Traditional Chin Med"},{"key":"R18-20240214","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R20-20240214","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R21-20240214","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R22-20240214","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R23-20240214","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R24-20240214","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0197-2456(97)00051-2","article-title":"Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis","volume":"18","author":"Pogue","year":"1997","journal-title":"Control Clin Trials"},{"key":"R25-20240214","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"R26-20240214","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.survophthal.2016.03.006","article-title":"Management of advanced glaucoma: characterization and monitoring","volume":"61","author":"de Moraes","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"R27-20240214","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2174\/1570159X15666170915142727","article-title":"Novel therapeutics in glaucoma management","volume":"16","author":"Bucolo","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"R28-20240214","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jep.2011.08.045","article-title":"An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis","volume":"141","author":"Lu","year":"2012","journal-title":"J Ethnopharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T16:09:37Z","timestamp":1707926977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021156"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":27,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021156","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}